469 filings
Page 4 of 24
8-K
2ncuj1jafzrc t5l
24 Jun 21
Submission of Matters to a Vote of Security Holders
5:01pm
DEFR14A
gpy1gb6db8294a5eqh
12 May 21
Revised proxy
4:21pm
8-K
2ycvugzm bv
5 May 21
Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results
4:19pm
8-K
cx2dzen5f14gzhc
5 Apr 21
Regulation FD Disclosure
8:08am
SEC STAFF
u9gv8 sm6
2 Apr 21
SEC staff action: Order
12:00am
8-K
bc3ykuvj4fb3ufve4hw4
8 Mar 21
Acadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of
4:30pm
SEC STAFF
o4v7b
5 Mar 21
SEC staff action: Order
12:00am
8-K
indwrdi2r qq0c905plg
24 Feb 21
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
4:10pm
8-K
09wrf
27 Jan 21
Departure of Directors or Certain Officers
5:26pm
8-K
2gx8qhs9571ofr0gruts
4 Nov 20
Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:37pm
8-K
fmibg4v3n4bvx2sbn3
1 Oct 20
Departure of Directors or Certain Officers
5:30pm
S-3ASR
nvpb48qt9 aej7ckyrhp
25 Aug 20
Automatic shelf registration
9:26am
8-K
jt5oar
25 Aug 20
ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to Portfolio
9:02am
8-K
kkr663d1o
6 Aug 20
Departure of Directors or Certain Officers
5:21pm
S-8
4xwqdn3jg1upsfjx0xv5
6 Aug 20
Registration of securities for employees
5:19pm